metricas
covid
Annals of Hepatology Most cited
Journal Information

Most cited

Data available in articles published since the year 2014

26
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Mi Zhou, Jianyu Lv, Xinli Chen, Yujie Shi, Guanqun Chao, Shuo Zhang
Ann Hepatol. 2025;30:101777
26
Full text access
13
Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045
Chengxia Kan, Kexin Zhang, Yuqun Wang, Xiaofei Zhang, Chang Liu, Yanhui Ma, Ningning Hou, Na Huang, ... Xiaodong Sun
Ann Hepatol. 2025;30:101898
13
Full text access
11
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, ... Mario G. Pessoa
Ann Hepatol. 2025;30:101903
11
Full text access
10
Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, Roberto Rueda-Esteban, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bömmel, ... Andreas Teufel
Ann Hepatol. 2025;30:101537
10
Full text access
9
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
Chenyang Mu, Sijie Wang, Zenghan Wang, Jian Tan, Haozan Yin, Yuefan Wang, Zhihui Dai, Dongyang Ding, Fu Yang
Ann Hepatol. 2025;30:101774
9
Full text access
9
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)
Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader
Ann Hepatol. 2025;30:101789
9
Full text access
7
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region
Saleh A. Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, Khalid Alswat, Mohamed Mawardi, Faisal M. Sanai, Faisal Abaakhail, Saad Alghamdi, ... Global NASH Council
Ann Hepatol. 2025;30:101569
7
Full text access
7
Is the liver resilient to the process of ageing?
Nirupama Chatterjee, Rishabh Sharma, Pratibha R Kale, Nirupma Trehanpati, Gayatri Ramakrishna
Ann Hepatol. 2025;30:101580
7
Full text access
6
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong, Yiwei Hao, Lei Sun, Ping Li, Junru Yang, Fuyang Zhang, Lingling He, Jing Zhang, Hongshan Wei
Ann Hepatol. 2025;30:101589
6
Full text access
6
EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway
Ling Wang, Chuanzhong Huang, Wansong Lin, Zhifeng Zhou, Jieyu Li, Mingshui Chen, Lingyu Zhang, Yunbin Ye
Ann Hepatol. 2025;30:101564
6
Full text access